This paper is in the following e-collection/theme issue:

Viewpoints and Perspectives (561) Patient-Reported Outcome Measures (PROMs) (320) Research Infrastructures and Registries (70) Immunology, Allergy, Rheumatology (106) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1554) mHealth in a Clinical Setting (665)

Published on in Vol 23, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28164, first published .
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry

A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry

A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry

Authors of this article:

Stefan Kleinert1, 2 Author Orcid Image ;   Peter Bartz-Bazzanella3 Author Orcid Image ;   Cay von der Decken3, 4 Author Orcid Image ;   Johannes Knitza5 Author Orcid Image ;   Torsten Witte6 Author Orcid Image ;   Sándor P Fekete7 Author Orcid Image ;   Matthias Konitzny7 Author Orcid Image ;   Alexander Zink8 Author Orcid Image ;   Georg Gauler9 Author Orcid Image ;   Patrick Wurth9 Author Orcid Image ;   Peer Aries10 Author Orcid Image ;   Kirsten Karberg11 Author Orcid Image ;   Christoph Kuhn12 Author Orcid Image ;   Florian Schuch1 Author Orcid Image ;   Susanna Späthling-Mestekemper13 Author Orcid Image ;   Wolfgang Vorbrüggen14 Author Orcid Image ;   Matthias Englbrecht15 Author Orcid Image ;   Martin Welcker16 Author Orcid Image ;   RHADAR Group17
Article Authors Cited by (15) Tweetations (1) Metrics

Journals

  1. Knitza J, Krusche M, Leipe J. Digitale Diagnoseunterstützung in der Rheumatologie. Zeitschrift für Rheumatologie 2021;80(10):909 View
  2. Knevel R, Knitza J, Hensvold A, Circiumaru A, Bruce T, Evans S, Maarseveen T, Maurits M, Beaart-van de Voorde L, Simon D, Kleyer A, Johannesson M, Schett G, Huizinga T, Svanteson S, Lindfors A, Klareskog L, Catrina A. Rheumatic?—A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A Multicenter Pilot Validation Study. Frontiers in Medicine 2022;9 View
  3. Welcker M, Mühlensiepen F, Knitza J, Popp F, Aries P. Digitalisierung in der Rheumapraxis. Zeitschrift für Rheumatologie 2021;80(9):835 View
  4. Becker C, Diener M, Hueber A, Henes J, Krusche M, Ignatyev Y, May S, Erstling U, Elling-Audersch C, Knitza J, Muehlensiepen F. Unmet Information Needs of Patients with Rheumatic Diseases: Results of a Cross-Sectional Online Survey Study in Germany. International Journal of Environmental Research and Public Health 2022;19(12):7071 View
  5. Kleinert S. Datenanalysen in Rheumapraxen. Zeitschrift für Rheumatologie 2021;80(9):827 View
  6. Knitza J, Janousek L, Kluge F, von der Decken C, Kleinert S, Vorbrüggen W, Kleyer A, Simon D, Hueber A, Muehlensiepen F, Vuillerme N, Schett G, Eskofier B, Welcker M, Bartz-Bazzanella P. Machine learning-based improvement of an online rheumatology referral and triage system. Frontiers in Medicine 2022;9 View
  7. Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, Popp F, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Englbrecht M, Vorbrüggen W, Adler G, Welcker M. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatology International 2022;43(1):89 View
  8. Englbrecht M, Bartz-Bazzanella P, von der Decken C, Gauler G, Wurth P, Aries P, Karberg K, Kuhn C, Schuch F, Späthling-Mestekemper S, Vorbrüggen W, Wendler J, Welcker M, Kleinert S. Prevalence of Depressive Symptoms in Patients With Psoriatic Arthritis: Have Numbers Changed During the COVID-19 Pandemic?. Frontiers in Medicine 2021;8 View
  9. Stenzel R, Hadaschik K, May S, Grahammer M, Labinsky H, Welcker M, Hornig J, Bendzuck G, Elling-Audersch C, Erstling U, Korbanka P, Vuillerme N, Heinze M, Krönke G, Schett G, Pecher A, Krusche M, Mucke J, Knitza J, Muehlensiepen F. Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study. BMC Health Services Research 2022;22(1) View
  10. Kleinert S, Schuch F, Rapp P, Ronneberger M, Wendler J, Sternad P, Popp F, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Welcker M. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices. Rheumatology International 2023;44(4):653 View
  11. Strunz P, Englbrecht M, Risser L, Witte T, Froehlich M, Schmalzing M, Gernert M, Schmieder A, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Heck J, Welcker M, Kleinert S. Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database. Frontiers in Immunology 2024;15 View
  12. Knitza J, Tascilar K, Fuchs F, Mohn J, Kuhn S, Bohr D, Muehlensiepen F, Bergmann C, Labinsky H, Morf H, Araujo E, Englbrecht M, Vorbrüggen W, von der Decken C, Kleinert S, Ramming A, Distler J, Bartz-Bazzanella P, Vuillerme N, Schett G, Welcker M, Hueber A. Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial. Journal of Medical Internet Research 2024;26:e55542 View
  13. Strunz P, Englbrecht M, Risser L, Witte T, Froehlich M, Schmalzing M, Gernert M, Schmieder A, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Heck J, Welcker M, Kleinert S. Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network. Rheumatology International 2024;44(10):2057 View
  14. Strunz P, Risser L, Englbrecht M, Witte T, Froehlich M, Schmalzing M, Gernert M, Hueper S, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Welcker M, Kleinert S. Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study. Frontiers in Immunology 2024;15 View
  15. Risser L, Witte T, Englbrecht M, Strunz P, Froehlich M, Schmalzing M, Gernert M, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Welcker M, Kleinert S. Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis – a retrospective analysis from the RHADAR database. Rheumatology International 2025;45(5) View